Pregnancy during and after cancer treatment: a retrospective single-center study

Abstract Background Pregnancy in women with a history of cancer or a new cancer diagnosis presents challenges for both oncological treatment and obstetric management. This study aimed to compare maternal, obstetric, and neonatal outcomes between cancer survivors and women diagnosed with cancer during pregnancy. Methods This retrospective single-center study included 36 women with cancer who were managed at a tertiary perinatology center between 2018 and 2025. Twenty-four patients had been diagnosed and treated before pregnancy, while 12 were diagnosed during pregnancy. Clinical characteristics, cancer types, treatment modalities, pregnancy complications, and fetal and neonatal outcomes were obtained from medical records. Continuous variables were compared using the independent-samples t-test and categorical variables using the Pearson chi-square test. A p value < 0.05 was considered statistically significant. Results Maternal age was similar between cancer survivors and women diagnosed during pregnancy (35 ± 5 vs. 35 ± 6 years, p = 0.90). Maternal complications did not differ significantly between the groups (20.8% vs. 16.7%, p = 0.766). Cesarean delivery was the predominant mode of delivery (75.0% vs. 60.0%, p = 0.420). After excluding pregnancy terminations, delivery before 34 weeks occurred in 12.5% of cancer survivors and 8.3% of women diagnosed during pregnancy. Mean birth weight was 3166 ± 591 g and 2784 ± 562 g, respectively (p = 0.15). Neonatal intensive care unit admission rates were similar (26.7% vs. 27.3%), while the 5-minute Apgar score was significantly lower among infants born to cancer survivors (8 vs. 9, p < 0.001). Conclusions Maternal and neonatal outcomes were generally favorable in both cancer survivors and women diagnosed with cancer during pregnancy. Similar rates of maternal complications, early preterm delivery, and neonatal intensive care unit admission suggest that favorable pregnancy outcomes can be achieved with individualized multidisciplinary management. Avoiding unnecessary early delivery when maternal condition and cancer treatment allow may further improve neonatal outcomes.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11233087/v1
Primary Topic
Pregnancy and Medication Impact
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pregnancy during and after cancer treatment: a retrospective single-center study

Gizem Kul, Münip Akalın, Ece Selen Tayyar, Esra Esim Büyükbayrak
2 links
Research Square
Pregnancy and Medication Impact
preprint

Pregnancy during and after cancer treatment: a retrospective single-center study

Gizem Kul, Münip Akalın, Ece Selen Tayyar, Esra Esim Büyükbayrak
preprint en

Abstract

Abstract Background Pregnancy in women with a history of cancer or a new cancer diagnosis presents challenges for both oncological treatment and obstetric management. This study aimed to compare maternal, obstetric, and neonatal outcomes between cancer survivors and women diagnosed with cancer during pregnancy. Methods This retrospective single-center study included 36 women with cancer who were managed at a tertiary perinatology center between 2018 and 2025. Twenty-four patients had been diagnosed and treated before pregnancy, while 12 were diagnosed during pregnancy. Clinical characteristics, cancer types, treatment modalities, pregnancy complications, and fetal and neonatal outcomes were obtained from medical records. Continuous variables were compared using the independent-samples t-test and categorical variables using the Pearson chi-square test. A p value < 0.05 was considered statistically significant. Results Maternal age was similar between cancer survivors and women diagnosed during pregnancy (35 ± 5 vs. 35 ± 6 years, p = 0.90). Maternal complications did not differ significantly between the groups (20.8% vs. 16.7%, p = 0.766). Cesarean delivery was the predominant mode of delivery (75.0% vs. 60.0%, p = 0.420). After excluding pregnancy terminations, delivery before 34 weeks occurred in 12.5% of cancer survivors and 8.3% of women diagnosed during pregnancy. Mean birth weight was 3166 ± 591 g and 2784 ± 562 g, respectively (p = 0.15). Neonatal intensive care unit admission rates were similar (26.7% vs. 27.3%), while the 5-minute Apgar score was significantly lower among infants born to cancer survivors (8 vs. 9, p < 0.001). Conclusions Maternal and neonatal outcomes were generally favorable in both cancer survivors and women diagnosed with cancer during pregnancy. Similar rates of maternal complications, early preterm delivery, and neonatal intensive care unit admission suggest that favorable pregnancy outcomes can be achieved with individualized multidisciplinary management. Avoiding unnecessary early delivery when maternal condition and cancer treatment allow may further improve neonatal outcomes.

Research Square
Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR), Marmara University (TR)
Good health and well-being
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon